title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	treatment_protocol_ch1	growth_protocol_ch1	growth_protocol_ch1.1	molecule_ch1	extract_protocol_ch1	extract_protocol_ch1.1	taxid_ch1	description	description.1	data_processing	data_processing.1	data_processing.2	data_processing.3	data_processing.4	data_processing.5	platform_id	contact_name	contact_email	contact_institute	contact_address	contact_city	contact_state	contact_zip/postal_code	contact_country	data_row_count	instrument_model	library_selection	library_source	library_strategy	relation	relation.1	supplementary_file_1	cell line type:ch1	cell type:ch1	treatment:ch1
iPS cell line Clone 1 No Dox Replicate 1	GSM5086593	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 1 No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 1	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC1ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925262	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110239	NONE	Clone 1	induced pluripotent stem cells	control
iPS cell line Clone 1 No Dox Replicate 2	GSM5086594	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 1 No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 1	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC1ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925261	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110240	NONE	Clone 1	induced pluripotent stem cells	control
iPS cell line Clone 1 Dox Replicate 1	GSM5086595	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 1 Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 1	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC1D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925260	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110241	NONE	Clone 1	induced pluripotent stem cells	doxycycline
iPS cell line Clone 1 Dox Replicate 2	GSM5086596	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 1 Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 1	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC1D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925259	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110242	NONE	Clone 1	induced pluripotent stem cells	doxycycline
iPS cell line Clone 5 No Dox Replicate 1	GSM5086597	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 5 No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 5	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC5ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925258	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110243	NONE	Clone 5	induced pluripotent stem cells	control
iPS cell line Clone 5 No Dox Replicate 2	GSM5086598	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 5 No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 5	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC5ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925243	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110244	NONE	Clone 5	induced pluripotent stem cells	control
iPS cell line Clone 5 Dox Replicate 1	GSM5086599	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 5 Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 5	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC5D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925283	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110245	NONE	Clone 5	induced pluripotent stem cells	doxycycline
iPS cell line Clone 5 Dox Replicate 2	GSM5086600	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 5 Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 5	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC5D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925319	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110246	NONE	Clone 5	induced pluripotent stem cells	doxycycline
iPS cell line Clone 5A No Dox Replicate 1	GSM5086601	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 5A No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 5A	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC5AND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925318	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110247	NONE	Clone 5A	induced pluripotent stem cells	control
iPS cell line Clone 5A No Dox Replicate 2	GSM5086602	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 5A No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 5A	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC5AND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925317	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110248	NONE	Clone 5A	induced pluripotent stem cells	control
iPS cell line Clone 5A Dox Replicate 1	GSM5086603	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 5A Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 5A	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC5AD_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925316	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110249	NONE	Clone 5A	induced pluripotent stem cells	doxycycline
iPS cell line Clone 5A Dox Replicate 2	GSM5086604	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 5A Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 5A	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC5AD_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925315	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110250	NONE	Clone 5A	induced pluripotent stem cells	doxycycline
iPS cell line Clone 7 No Dox Replicate 1	GSM5086605	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 7 No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 7	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC7ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925314	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110251	NONE	Clone 7	induced pluripotent stem cells	control
iPS cell line Clone 7 No Dox Replicate 2	GSM5086606	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 7 No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 7	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC7ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925313	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110252	NONE	Clone 7	induced pluripotent stem cells	control
iPS cell line Clone 7 Dox Replicate 1	GSM5086607	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 7 Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 7	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC7D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925312	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110253	NONE	Clone 7	induced pluripotent stem cells	doxycycline
iPS cell line Clone 7 Dox Replicate 2	GSM5086608	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Clone 7 Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Clone 7	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRANSC7D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925311	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110254	NONE	Clone 7	induced pluripotent stem cells	doxycycline
iPS cell line Trisomy (31627H) No Dox Replicate 1	GSM5086609	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Trisomy (31627H) No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Trisomy (31627H)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRI31627HND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925310	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110255	NONE	Trisomy (31627H)	induced pluripotent stem cells	control
iPS cell line Trisomy (31627H) No Dox Replicate 2	GSM5086610	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Trisomy (31627H) No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Trisomy (31627H)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRI31627HND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925309	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110256	NONE	Trisomy (31627H)	induced pluripotent stem cells	control
iPS cell line Trisomy (31627H) Dox Replicate 1	GSM5086611	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Trisomy (31627H) Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Trisomy (31627H)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRI31627HD_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925308	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110257	NONE	Trisomy (31627H)	induced pluripotent stem cells	doxycycline
iPS cell line Trisomy (31627H) Dox Replicate 2	GSM5086612	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Trisomy (31627H) Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Trisomy (31627H)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRI31627HD_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925307	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110258	NONE	Trisomy (31627H)	induced pluripotent stem cells	doxycycline
iPS cell line Trisomy (32436B) No Dox Replicate 1	GSM5086613	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Trisomy (32436B) No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Trisomy (32436B)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRI32436BND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925306	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110259	NONE	Trisomy (32436B)	induced pluripotent stem cells	control
iPS cell line Trisomy (32436B) No Dox Replicate 2	GSM5086614	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Trisomy (32436B) No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Trisomy (32436B)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRI32436BND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925305	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110260	NONE	Trisomy (32436B)	induced pluripotent stem cells	control
iPS cell line Trisomy (32436B) Dox Replicate 1	GSM5086615	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Trisomy (32436B) Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Trisomy (32436B)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRI32436BD_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925304	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110261	NONE	Trisomy (32436B)	induced pluripotent stem cells	doxycycline
iPS cell line Trisomy (32436B) Dox Replicate 2	GSM5086616	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Trisomy (32436B) Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Trisomy (32436B)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	TRI32436BD_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925303	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110262	NONE	Trisomy (32436B)	induced pluripotent stem cells	doxycycline
iPS cell line Disomy (32316) No Dox Replicate 1	GSM5086617	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (32316) No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (32316)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS32316ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925302	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110263	NONE	Disomy (32316)	induced pluripotent stem cells	control
iPS cell line Disomy (32316) No Dox Replicate 2	GSM5086618	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (32316) No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (32316)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS32316ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925301	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110264	NONE	Disomy (32316)	induced pluripotent stem cells	control
iPS cell line Disomy (32316) Dox Replicate 1	GSM5086619	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (32316) No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (32316)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS32316D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925300	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110265	NONE	Disomy (32316)	induced pluripotent stem cells	doxycycline
iPS cell line Disomy (32316) Dox Replicate 2	GSM5086620	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (32316) No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (32316)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS32316D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925299	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110266	NONE	Disomy (32316)	induced pluripotent stem cells	doxycycline
iPS cell line Disomy (322-2) No Dox Replicate 1	GSM5086621	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (322-2) No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (322-2)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS322-2ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925298	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110267	NONE	Disomy (322-2)	induced pluripotent stem cells	control
iPS cell line Disomy (322-2) No Dox Replicate 2	GSM5086622	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (322-2) No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (322-2)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS322-2ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925296	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110268	NONE	Disomy (322-2)	induced pluripotent stem cells	control
iPS cell line Disomy (322-2) Dox Replicate 1	GSM5086623	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (322-2) Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (322-2)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS322-2D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925295	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110269	NONE	Disomy (322-2)	induced pluripotent stem cells	doxycycline
iPS cell line Disomy (322-2) Dox Replicate 2	GSM5086624	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (322-2) Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (322-2)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS322-2D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925294	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110270	NONE	Disomy (322-2)	induced pluripotent stem cells	doxycycline
iPS cell line Disomy (322-3) No Dox Replicate 1	GSM5086625	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (322-3) No Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (322-3)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS322-3ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925293	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110271	NONE	Disomy (322-3)	induced pluripotent stem cells	control
iPS cell line Disomy (322-3) No Dox Replicate 2	GSM5086626	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (322-3) No Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (322-3)	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS322-3ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925292	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110272	NONE	Disomy (322-3)	induced pluripotent stem cells	control
iPS cell line Disomy (322-3) Dox Replicate 1	GSM5086627	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (322-3) Dox Replicate 1	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (322-3)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS322-3D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925291	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110273	NONE	Disomy (322-3)	induced pluripotent stem cells	doxycycline
iPS cell line Disomy (322-3) Dox Replicate 2	GSM5086628	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS cell line Disomy (322-3) Dox Replicate 2	Homo sapiens	cell type: induced pluripotent stem cells	cell line type: Disomy (322-3)	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	IPSCD6_DE_Summary.tab.txt	DIS322-3D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925290	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110274	NONE	Disomy (322-3)	induced pluripotent stem cells	doxycycline
iPS-derived Endothelial Cell Clone 1 No Dox Replicate 1	GSM5086629	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 1 No Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 1	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC1ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925256	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110275	NONE	Clone 1	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 1 No Dox Replicate 2	GSM5086630	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 1 No Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 1	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC1ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925255	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110276	NONE	Clone 1	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 1 No Dox Replicate 3	GSM5086631	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 1 No Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 1	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC1ND_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925254	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110277	NONE	Clone 1	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 1 Dox Replicate 1	GSM5086632	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 1 Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 1	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC1D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925253	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110278	NONE	Clone 1	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 1 Dox Replicate 2	GSM5086633	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 1 Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 1	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC1D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925289	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110279	NONE	Clone 1	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 1 Dox Replicate 3	GSM5086634	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 1 Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 1	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC1D_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925257	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110280	NONE	Clone 1	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 5 No Dox Replicate 1	GSM5086635	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5 No Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925252	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110281	NONE	Clone 5	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 5 No Dox Replicate 2	GSM5086636	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5 No Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925251	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110282	NONE	Clone 5	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 5 No Dox Replicate 3	GSM5086637	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5 No Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5ND_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925249	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110283	NONE	Clone 5	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 5 Dox Replicate 1	GSM5086638	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5 Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925248	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110284	NONE	Clone 5	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 5 Dox Replicate 2	GSM5086639	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5 Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925247	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110285	NONE	Clone 5	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 5 Dox Replicate 3	GSM5086640	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5 Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5D_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925246	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110286	NONE	Clone 5	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 5A No Dox Replicate 1	GSM5086641	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5A No Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5A	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5AND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925245	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110287	NONE	Clone 5A	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 5A No Dox Replicate 2	GSM5086642	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5A No Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5A	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5AND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925244	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110288	NONE	Clone 5A	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 5A No Dox Replicate 3	GSM5086643	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5A No Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5A	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5AND_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925336	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110289	NONE	Clone 5A	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 5A Dox Replicate 1	GSM5086644	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5A Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5A	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5AD_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925335	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110290	NONE	Clone 5A	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 5A Dox Replicate 2	GSM5086645	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5A Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5A	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5AD_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925334	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110291	NONE	Clone 5A	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 5A Dox Replicate 3	GSM5086646	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 5A Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 5A	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC5AD_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925333	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110292	NONE	Clone 5A	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 7 No Dox Replicate 1	GSM5086647	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 7 No Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 7	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC7ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925332	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110293	NONE	Clone 7	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 7 No Dox Replicate 2	GSM5086648	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 7 No Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 7	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC7ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925331	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110294	NONE	Clone 7	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 7 No Dox Replicate 3	GSM5086649	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 7 No Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 7	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC7ND_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925330	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110295	NONE	Clone 7	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Clone 7 Dox Replicate 1	GSM5086650	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 7 Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 7	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC7D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925329	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110296	NONE	Clone 7	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 7 Dox Replicate 2	GSM5086651	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 7 Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 7	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC7D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925328	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110297	NONE	Clone 7	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Clone 7 Dox Replicate 3	GSM5086652	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Clone 7 Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Clone 7	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRANSC7D_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925327	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110298	NONE	Clone 7	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Trisomy (31627H) No Dox Replicate 1	GSM5086653	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Trisomy (31627H) No Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Trisomy 31627H	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRI31627HND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925326	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110299	NONE	Trisomy 31627H	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Trisomy (31627H) No Dox Replicate 2	GSM5086654	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Trisomy (31627H) No Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Trisomy 31627H	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRI31627HND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925325	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110300	NONE	Trisomy 31627H	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Trisomy (31627H) No Dox Replicate 3	GSM5086655	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Trisomy (31627H) No Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Trisomy 31627H	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRI31627HND_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925324	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110301	NONE	Trisomy 31627H	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Trisomy (31627H) Dox Replicate 1	GSM5086656	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Trisomy (31627H) Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Trisomy 31627H	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRI31627HD_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925323	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110302	NONE	Trisomy 31627H	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Trisomy (31627H) Dox Replicate 2	GSM5086657	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Trisomy (31627H) Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Trisomy 31627H	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRI31627HD_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925322	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110303	NONE	Trisomy 31627H	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Trisomy (31627H) Dox Replicate 3	GSM5086658	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Trisomy (31627H) Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Trisomy 31627H	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_TRI31627HD_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925288	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110304	NONE	Trisomy 31627H	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Disomy (322-3) No Dox Replicate 1	GSM5086659	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Disomy (322-3) No Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Disomy 322-3	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_DIS322-3ND_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925287	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110305	NONE	Disomy 322-3	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Disomy (322-3) No Dox Replicate 2	GSM5086660	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Disomy (322-3) No Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Disomy 322-3	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_DIS322-3ND_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925286	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110306	NONE	Disomy 322-3	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Disomy (322-3) No Dox Replicate 3	GSM5086661	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Disomy (322-3) No Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Disomy 322-3	treatment: control	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_DIS322-3ND_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925285	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110307	NONE	Disomy 322-3	iPS cell line derived Endothelial Cells	control
iPS-derived Endothelial Cell Disomy (322-3) Dox Replicate 1	GSM5086662	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Disomy (322-3) Dox Replicate 1	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Disomy 322-3	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_DIS322-3D_Rep1	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925284	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110308	NONE	Disomy 322-3	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Disomy (322-3) Dox Replicate 2	GSM5086663	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Disomy (322-3) Dox Replicate 2	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Disomy 322-3	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_DIS322-3D_Rep2	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925321	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110309	NONE	Disomy 322-3	iPS cell line derived Endothelial Cells	doxycycline
iPS-derived Endothelial Cell Disomy (322-3) Dox Replicate 3	GSM5086664	Public on Jul 05 2022	Feb 16 2021	Jul 05 2022	SRA	1	iPS-derived Endothelial Cell Disomy (322-3) Dox Replicate 3	Homo sapiens	cell type: iPS cell line derived Endothelial Cells	cell line type: Disomy 322-3	treatment: doxycycline	- or + doxycycline (500 ng/ml); 6 days for iPS cells and 14 days for iPS-derived endothelial cells	Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	iPS cells were grown in feeder free conditions on vitronectin coated plates and cultured in Essential E8 medium (Invitrogen). Differentiation of iPS cells into endothelial cells were adapted from Lian et al. (2014) and Patsch et al. (2015). Cells were treated with 8 uM CHIR99021 (Tocris Bioscience) for on day 0 and day 1, and 2 uM CHIR99021 on day 2-4. Day 5, cells were collected for CD34+ were selected using the CD34 MicroBead Kit (Miltenyi Biotec). Purified CD34 cells were cultured on collagen coated plates with EGM-2 media (Lonza) supplemented with 25 ng/ml VEGF165 (PEPROTECH).	polyA RNA	RNA samples were extracted using Trizol Reagent (ThermoFisher) adapted from the manufacturer’s instructions, using 100% ethanol in place of isopropanol. Precipitated RNA was resuspended in RNase- and DNase-free water and DNA digestion was performed using DNase I (Roche) with 2U/ul of RNasin Plus (Promega) for 1 hr at room temperature. RNeasy Mini Kit was used for RNA purification and DNase I removal following the RNA Cleanup protocol from the manufacturer’s instructions.	The NEBNext Ultra™ II Directional RNA Library Prep Kit for Illumina, NEBNext Poly(A) mRNA Magnetic Isolation Module, and NEBNext Multiplex Oligos for Illumina were used to prepare sequencing libraries following the manufacturer’s instructions (New England Biolabs, Inc). All libraries were prepared with 1 ug of starting RNA.	9606	EC_DE_Summary.tab.txt	EC_DIS322-3D_Rep3	For all samples, FastQC was used to evaluate quality of data.	Libraries were aligned to genome build GRch38 using HISAT2 (Kim et al., 2015, 2019)	Mapped reads were quantified using featureCounts (Liao et al., 2014).	Differential expression analysis was conducted by using the R package edgeR (McCarthy et al. 2012)	Genome_build: GRch38	Supplementary_files_format_and_content: Tab delimited files containg differentially expressed genes generated by edgeR within R (McCarthy et al., 2012)	GPL20301	Jennifer,Eunmi,Moon	Jennifer.Moon@umassmed.edu	University of Massachusetts Medical School	55 Lake Ave N	Worcester	MA	01655	USA	0	Illumina HiSeq 4000	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN17925320	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX10110310	NONE	Disomy 322-3	iPS cell line derived Endothelial Cells	doxycycline
